ImClone/Bristol Aim To Expand Erbitux’s Reach To Asia
Development partners broker deal with Merck KGaA to bring the first EGFR receptor-inhibiting monoclonal antibody to Japan.
Development partners broker deal with Merck KGaA to bring the first EGFR receptor-inhibiting monoclonal antibody to Japan.